ARIC Publications
Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study." Int J Cardiol. 2017;241:223-228.
"Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study." J Thromb Haemost. 2019;17(5):818-826.
"Circulating electrolytes and the prevalence of atrial fibrillation and supraventricular ectopy: The Atherosclerosis Risk in Communities (ARIC) study." Nutr Metab Cardiovasc Dis. 2020;30(7):1121-1129.
"Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(5):e001082.
"Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort." Heart. 2014;100(19):1511-6.
"Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals." Circ Res. 2019;125(8):773-782.
"Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study." Diabetologia. 2007;50(1):36-42.
"CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race." Am J Kidney Dis. 2013;62(4):691-702.
"CKD and Risk of Incident Hospitalization With Clostridioides difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2022;80(2):297-299.
"Classification of acute decompensated heart failure: an automated algorithm compared with a physician reviewer panel: the Atherosclerosis Risk in Communities study." Circ Heart Fail. 2013;6(4):719-26.
"Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria." Circ Heart Fail. 2012;5(2):152-9.
"Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)." Am J Cardiol. 2021.
"Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2009;54(25):2388-95.
"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)." Am J Cardiol. 2011;107(1):85-91.
"Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2007;190(2):459-64.
"Clinically Recognized Varicose Veins and Physical Function in Older Individuals: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2022;77(8):1637-1643.
"Clonal Hematopoiesis Is Associated With Higher Risk of Stroke." Stroke. 2022;53(3):788-797.
"Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease." Nat Commun. 2022;13(1):5350.
"Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1996;45(6):699-706.
"Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease." J Atheroscler Thromb. 2010;17(4):402-9.
"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)." Am J Med. 2002;113(8):636-42.
"Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology." Blood. 2009;114(14):2878-83.
"Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study." Am J Epidemiol. 2006;164(11):1075-84.
"Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(2):214-222.
"Coffee consumption and liver-related hospitalizations and deaths in the ARIC study." Eur J Clin Nutr. 2019;73(8):1133-1140.
"Coffee consumption and plasma homocyst(e)ine: results from the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1997;66(6):1475-7.
"Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From the Atherosclerosis Risk in Communities Study." Kidney Int Rep. 2022;7(7):1665-1672.
"Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2009;169(12):1445-53.
"Cognition and 20-year subsequent sleep disturbances." Sleep Health. 2021.
"Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study." Neuroepidemiology. 2013;40(2):117-24.
"Cognitive decline and oral health in middle-aged adults in the ARIC study." J Dent Res. 2013;92(9):795-801.
"Cognitive decline in older adults: What can we learn from optical coherence tomography (OCT)-based retinal vascular imaging?" J Am Geriatr Soc. 2021;69(9):2524-2535.
"Cognitive functioning as a predictor of ischemic stroke incidence." Epidemiology. 2003;14(6):673-9.
"Cognitive impairment and intracranial atherosclerotic stenosis in general population." Neurology. 2018;90(14):e1240-e1247.
"Cognitive Reserve in Midlife is not Associated with Amyloid-β Deposition in Late-Life." J Alzheimers Dis. 2019;68(2):517-521.
"Cohort profile: the chronic kidney disease prognosis consortium." Int J Epidemiol. 2013;42(6):1660-8.
"Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis." Circulation. 1996;94(5):922-7.
"A cohort study of the impact of tooth loss and periodontal disease on respiratory events among COPD subjects: modulatory role of systemic biomarkers of inflammation." PLoS One. 2013;8(8):e68592.
"A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk." Cancer Res. 2019;79(1):274-285.
" "Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2012;60(2):207-16.
"Combined linkage and association analysis identifies rare and low frequency variants for blood pressure at 1q31." Eur J Hum Genet. 2019;27(2):269-277.
"Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults." J Am Heart Assoc. 2020;9(15):e015410.
"A common allele on chromosome 9 associated with coronary heart disease." Science. 2007;316(5830):1488-91.
"Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval." Circ Genom Precis Med. 2018;11(5):e002037.
"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project." Blood. 2013;122(4):590-7.
"A common biological basis of obesity and nicotine addiction." Transl Psychiatry. 2013;3:e308.
"Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study." Eur Heart J. 2012;33(2):183-90.
"Common Coding Variants in Are Associated With the Nav1.8 Late Current and Cardiac Conduction." Circ Genom Precis Med. 2018;11(5):e001663.
"A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation." Circ Arrhythm Electrophysiol. 2011;4(1):87-93.
"Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities." Stroke. 2020;51(7):2111-2121.
"Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants." Heart Rhythm. 2013;10(3):401-8.
"Common Medications and Intracerebral Hemorrhage: The ARIC Study." J Am Heart Assoc. 2021;10(5):e014270.
"Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease." Hum Genet. 2008;123(4):399-408.
"A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans." J Cardiovasc Electrophysiol. 2014;25(11):1150-7.
"Common variants associated with plasma triglycerides and risk for coronary artery disease." Nat Genet. 2013;45(11):1345-52.
"Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways." Diabetes. 2010;59(12):3229-39.
"Common variants at 12q14 and 12q24 are associated with hippocampal volume." Nat Genet. 2012;44(5):545-51.
"Common variants at 6p21.1 are associated with large artery atherosclerotic stroke." Nat Genet. 2012;44(10):1147-51.
"Common variants at ten loci modulate the QT interval duration in the QTSCD Study." Nat Genet. 2009;41(4):407-14.
"Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction." Nat Genet. 2010;42(12):1068-76.
"Common variants in KCNN3 are associated with lone atrial fibrillation." Nat Genet. 2010;42(3):240-4.
"Common variants in Mendelian kidney disease genes and their association with renal function." J Am Soc Nephrol. 2013;24(12):2105-17.
"Common variants in the GDF5-UQCC region are associated with variation in human height." Nat Genet. 2008;40(2):198-203.
"Common variation in fatty acid metabolic genes and risk of incident sudden cardiac arrest." Heart Rhythm. 2014;11(3):471-7.
"Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance." PLoS One. 2017;12(8):e0181373.
"Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence." J Am Coll Cardiol. 2011;57(16):1690-6.
"Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience." J Clin Epidemiol. 1996;49(2):223-33.
"A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study." Arch Intern Med. 1999;159(15):1777-83.
"Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of centers for medicare and medicaid services in the atherosclerosis risk in communities study." PLoS One. 2014;9(4):e94321.
"A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study." Ethn Health. 2014;19(6):601-16.
"Comparative associations of diabetes risk factors with five measures of hyperglycemia." BMJ Open Diabetes Res Care. 2014;2(1):e000002.
"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study." Lancet Diabetes Endocrinol. 2017;5(1):34-42.
"Comparing data-driven and hypothesis-driven MRI-based predictors of cognitive impairment in individuals from the Atherosclerosis Risk in Communities (ARIC) study." Alzheimers Dement. 2021.
"Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes." BMJ Open Diabetes Res Care. 2019;7(1):e000794.
"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies." Hum Mol Genet. 2015;24(8):2125-37.
"Comparison of carotid plaque ulcer detection using contrast-enhanced and time-of-flight MRA techniques." AJNR Am J Neuroradiol. 2013;34(1):177-84.
"Comparison of computer-assigned Minnesota Codes with the visual standard method for new coronary heart disease events." Am J Epidemiol. 2000;151(8):790-7.
"Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA." Int J Epidemiol. 2000;29(5):837-44.
"Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study." PLoS One. 2017;12(1):e0167742.
"